The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

13 Jun 2012 07:00

RNS Number : 2299F
Sopheon PLC
13 June 2012
 



SOPHEON PLC

 

AGM Statement

 

At the Annual General Meeting of Sopheon plc to be held later today, the chairman of the board will give shareholders an update and review of the business. This will include the following statement:

 

"After strong growth in 2010, we reported 2011 revenues broadly similar to the prior year at £10.3m. EBITDA of £1.5m was also essentially the same as 2010, and in line with market expectations. Thanks to strict control of costs and enhanced conversion of development work into standard products, we achieved these results despite the expansion of staff in sales, services and development. For the second year in a row, we are also pleased to report a positive bottom-line profit after tax of £104,000.

 

Last year was characterized by strong demand from our client base for extension business, which absorbed the attention of our sales team. One consequence was that sales efforts were less focused on generating completely new accounts. We have now reorganized our sales resources to drive more balanced attention to both new account acquisition and generating additional growth out of our client base. We have already seen an improvement in new client acquisition compared to last year. We believe this will be reflected in improved license performance in 2012. In early 2011, we grew staff levels in key areas. These levels were maintained until recently, when increased demand led us to make further controlled expansion of staff. In particular, we advanced our market presence across Europe with the addition of two sales representatives. We also added technical resources across the business in response to growing service requirements. These hires were made with due caution given that global markets have not yet regained their poise.

 

During 2011, we introduced a new agile development methodology which has improved our ability to build products faster, and do a better job of ensuring that they are in step with real customer needs. A major product milestone was achieved with the release of Accolade 8.0, offering enhanced support for project portfolio management and collaboration, integration with Microsoft's SharePoint® and a mobile application for use with iPhone® and iPad® devices. We have also collaborated with Kalypso, the global innovation consulting firm and Sopheon partner, to introduce a new offering called FEI OptimizerTM that will help consumer goods manufacturers increase the value of new products by improving ideation and concept development.

 

On the corporate front, we successfully extended the maturity of the group's £850,000 convertible loan by two years to January 2015, coupled with a modification of the conversion price to 5p. In addition, we are today requesting shareholders to approve the transfer of Sopheon's listing from NYSE Euronext in Amsterdam to NYSE Alternext, an exciting market that is a better match for our corporate profile. This change is also subject to regulatory approval.

 

Full year 2012 revenue visibility from contracted business and recurring revenue streams has now risen to £7.5 million compared to £6.5 million announced on 3 May, and £6.6 million at the time of our AGM statement a year ago. We expect this to translate into higher reported first-half revenues than in 2011. In addition, we are working to close a substantial amount of business in the remaining weeks of June. Accurate prediction of the timing and value of sales events remains difficult, but if closed this month, the new business would further boost first-half performance." 

 

Sopheon's annual report and accounts for the year ended 31 December 2011 has been provided to shareholders and is available from the Company's website www.sopheon.com.

 

For further information contact:

Barry Mence, ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Charlotte StrannerHenrik PerssonVictoria Bates

finnCap

+ 44 (0) 20 7600 1658

Guy McDougallHeather Armstrong

Newgate Threadneedle

+ 44 (0) 20 7653 9842

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

 

About Sopheon

Sopheon (LSE: SPE) is an international provider of software and services. Sopheon's solutions structure, align and manage innovation processes to help organizations generate more revenues and profits from new products. Sopheon's solutions are used by industry leaders throughout the world, including BAE Systems, BASF, Corning, Electrolux, Honeywell, Novartis and SABMiller. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com. 

 

Revenue visibility is defined in Note4 of Sopheon's 2011 annual report which is available from the investor section of www.sopheon.com .

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLLFLRRTIFLIF
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.